Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: The efficacy and safety of peripheral intravenous parenteral nutrition vs 10% glucose in preterm infants born 30 to 33 weeks’ gestation: a randomised controlled trial

Variable P-PN (n = 42) Control (n = 50)
Infant characteristics
 Female sex 17 (40) 17 (34)
 Gestational age, median (IQR), wks 32 (31–32) 32 (31–33)
 30+ 0–31+ 6 weeks’ gestation 15 (36) 19 (38)
 32+ 0–33+ 6 weeks’ gestation 27 (64) 31 (62)
 Singleton 18 (43) 32 (64)
 Twins 18 (43) 15 (30)
 Triplets 6 (14) 3 (6)
 Apgar at 5 min, median (IQR) (n = 41/50) 9.0 (8.0–9.0) 8.5 (8.0–9.0)
 Birth weight, mean (SD), g 1717 (289) 1749 (329)
  Birth weight z-score, mean (SD) −0.2 (0.7) −0.1 (0.7)
 Birth length, mean (SD), cm 42 (2) 42 (2)
 Birth head circumference, mean (SD), cm 30 (2) 30 (2)
Maternal characteristics
 Maternal age, mean (SD), yr 32 (5) 31 (5)
 Vaginal birth 14 (33) 15 (30)
 Caesarean section 28 (67) 35 (70)
 Antenatal steroids - any 24 (57) 35 (70)
  1. Data are presented as n (%) unless otherwise indicated